Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
7.08
-0.20 (-2.75%)
At close: Jun 17, 2025, 3:59 PM
7.05
-0.49%
After-hours: Jun 17, 2025, 04:04 PM EDT
-2.75% (1D)
| Bid | 6.71 |
| Market Cap | 151.45M |
| Revenue (ttm) | 64.46M |
| Net Income (ttm) | -96.42M |
| EPS (ttm) | -4.53 |
| PE Ratio (ttm) | -1.56 |
| Forward PE | -2.36 |
| Analyst | Buy |
| Ask | 7.48 |
| Volume | 106,765 |
| Avg. Volume (20D) | 194,380 |
| Open | 7.24 |
| Previous Close | 7.28 |
| Day's Range | 7.03 - 7.44 |
| 52-Week Range | 4.09 - 17.23 |
| Beta | 0.77 |
About ENTA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENTA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+14.31%
Enanta Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
4 months ago
+14.08%
Enanta Pharmaceuticals shares are trading higher after the company reported Q1 financial results and beat its EPS estimate.
